- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 409/02 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
Patent holdings for IPC class C07D 409/02
Total number of patents in this class: 115
10-year publication summary
|
4
|
9
|
9
|
8
|
6
|
2
|
5
|
4
|
8
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MyoKardia, Inc. | 114 |
6 |
| Allergan, Inc. | 2159 |
4 |
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
4 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 321 |
4 |
| Janssen Pharmaceutica N.V. | 3161 |
3 |
| Merck Patent GmbH | 5735 |
3 |
| Sanford Burnham Prebys Medical Discovery Institute | 310 |
3 |
| FUJIFILM Corporation | 30562 |
2 |
| Idemitsu Kosan Co., Ltd. | 4251 |
2 |
| CalciMedica, Inc. | 92 |
2 |
| Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 53 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 686 |
2 |
| Phillips 66 Company | 1018 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 715 |
2 |
| Solarmer Energy, Inc. | 10 |
2 |
| Vanderbilt University | 2026 |
2 |
| Celloram Inc. | 11 |
2 |
| Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. | 8 |
2 |
| Xenolis Pte. Ltd. | 4 |
2 |
| Bristol-myers Squibb Company | 4748 |
1 |
| Other owners | 63 |